Join
Live feed
·
INSIDERFilingvia Quantisnow
Fate Therapeutics Inc. logo

SEC Form 4: Dulac Edward J Iii sold $13,210 worth of shares (4,718 units at $2.80), decreasing direct ownership by 4% to 119,570 units

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FATE (Fate Therapeutics Inc.) and more on Quantisnow.